Making Informed Decisions About GLP-1 Medications The latest news about GLP-1 medications shows both their promise and the importance of using them safely
Hansen LS, Sparre-Ulrich AH, Christensen M, et al
As Novo Nordisk rode $18.5 billion high on semaglutide profits, the company announced it would discontinue one of its insulin products
Jelly went to the funeral and saw the boy and touched his face
The suits come as the use of the blockbuster drugs has skyrocketed, embraced by millions of Americans to manage diabetes, lower the risk of heart disease and lose weight
When GLP-1 levels rise after eating, the hormone stimulates insulin secretion in a glucose-dependent manner, meaning insulin is only released when blood glucose levels are elevated